病例报告:在Bardet-Biedl综合征患者中,Setmelanotide启动后认知功能得到改善
Menjin Kuk1, Jesse Richards2, Rachel A Ross1
1Dominick Purpura Department of Neuroscience and Department of Psychiatry, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, United States.
Frontiers in endocrinology
|October 6, 2025
概括
用setmelanotide治疗体重管理的巴德特-比德尔综合征 (BBS) 患者的食欲下降. 这种治疗也显著改善了认知和情感功能,表明了超出代谢控制的更广泛的治疗效果.
科学领域:
- 遗传学和罕见疾病.
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
背景情况:
- 巴德特-比德尔综合征 (BBS) 是一种罕见的遗传疾病,影响多个器官系统.
- BBS的特点是代谢障碍,如肥胖和过,由于瘦素-黑色素-4受体 (MC4R) 信号受损.
- 塞特梅拉诺提德是一种MC4R激动剂,已被批准用于管理BBS患者的肥胖和过.
研究的目的:
- 报告一个用setmelanotide治疗的BBS病例.
- 评估setmelanotide对BBS患者体重管理,食欲和认知/情感功能的影响.
- 为了突出setmelanotide的潜在非代谢益处.
主要方法:
- 一个BBS患者的病例报告开始使用setmelanotide来控制体重.
- 在开始治疗之前和之后评估食欲,认知功能 (使用WAIS-IV) 和情感功能.
- 临床观察和精神状态检查.
主要成果:
- 患者在开始服用梅拉诺提德后一个月报告食欲下降.
- 与基线相比,在认知和情感功能方面观察到显著的改善.
- 这些改善在心理状态检查和WAIS-IV测试表现中被注意到.
结论:
- 在BBS患者中,setmelanotide治疗导致食欲下降,认知和情感功能得到改善.
- 这一案例表明,setmelanotide可能在BBS的代谢领域之外具有有益的影响.
- 需要进一步的研究来探索塞特梅拉诺提德对BBS神经和心理方面的更广泛影响.
更多相关视频
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
1.5K
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
623
相关概念视频
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...